Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ELI LILLY & Co | 26,626.5 | reported | 09 Feb 2026 | tx 24+46,489.71−31,801.22 |
| Loxo Oncology, Inc. | 0 | reported | 15 Feb 2019 | tx 225+472,525−732,937 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 09 Feb 2026 | GRANT_AWARD | ELI LILLY & Co | 4,865.89 | 1044.67 USD | |
| 01 Feb 2026 | TAX_WITHHOLDING | ELI LILLY & Co | 1,909.38 | 1037.15 USD | |
| 01 Feb 2026 | EXERCISE | ELI LILLY & Co | 4,108 | 0.00 USD | |
| 01 Feb 2026 | EXERCISE | ELI LILLY & Co | 4,108 | 0.00 USD | deriv |
| 13 Aug 2025 | PURCHASE | ELI LILLY & Co | 1,000 | 647.36 USD | |
| 10 Feb 2025 | GRANT_AWARD | ELI LILLY & Co | 6,103.82 | 868.88 USD | |
| 10 Feb 2025 | GRANT_AWARD | ELI LILLY & Co | 4,108 | 0.00 USD | deriv |
| 01 Feb 2025 | EXERCISE | ELI LILLY & Co | 3,023 | 0.00 USD | |
| 01 Feb 2025 | TAX_WITHHOLDING | ELI LILLY & Co | 1,409.84 | 811.08 USD | |
| 01 Feb 2025 | EXERCISE | ELI LILLY & Co | 3,023 | 0.00 USD | deriv |
| 31 Oct 2024 | GIFT | ELI LILLY & Co | 4,302 | 0.00 USD | |
| 12 Feb 2024 | GRANT_AWARD | ELI LILLY & Co | 2,369 | 737.26 USD | |
| 12 Feb 2024 | GRANT_AWARD | ELI LILLY & Co | 3,023 | 0.00 USD | deriv |
| 01 Feb 2024 | TAX_WITHHOLDING | ELI LILLY & Co | 1,685 | 645.61 USD | |
| 01 Feb 2024 | EXERCISE | ELI LILLY & Co | 3,618 | 0.00 USD | |
| 01 Feb 2024 | EXERCISE | ELI LILLY & Co | 3,618 | 0.00 USD | deriv |
| 16 Feb 2023 | EXERCISE | ELI LILLY & Co | 2,785 | 0.00 USD | |
| 16 Feb 2023 | TAX_WITHHOLDING | ELI LILLY & Co | 1,314 | 335.01 USD | |
| 16 Feb 2023 | EXERCISE | ELI LILLY & Co | 2,785 | 0.00 USD | deriv |
| 10 Feb 2023 | GRANT_AWARD | ELI LILLY & Co | 2,407 | 345.12 USD | |
| 16 Feb 2022 | TAX_WITHHOLDING | ELI LILLY & Co | 2,186 | 243.84 USD | |
| 16 Feb 2022 | EXERCISE | ELI LILLY & Co | 5,461 | 0.00 USD | |
| 16 Feb 2022 | EXERCISE | ELI LILLY & Co | 5,461 | 0.00 USD | deriv |
| 28 Dec 2021 | GRANT_AWARD | ELI LILLY & Co | 3,618 | 0.00 USD | deriv |
| 15 Feb 2019 | OTHER | Loxo Oncology, Inc. | 19,000 | 235.00 USD |